Characteristics | Cases (n = 182) | Percentage (%) |
---|---|---|
Age (years) | ||
 Median (range) | 49 (24–76) |  |
 < 60 | 156 | 85.7 |
 ≥ 60 | 26 | 14.3 |
Gender | ||
 Male | 132 | 72.5 |
 Female | 50 | 27.5 |
Smoking status | ||
 Non-smoker | 151 | 83 |
 Smoker | 31 | 17 |
EBV status | ||
 Positive | 115 | 63.2 |
 Negative | 67 | 36.8 |
Family history | ||
 Yes | 26 | 14.3 |
 No | 156 | 85.7 |
Pathological type | ||
 I | 14 | 7.7 |
 II | 41 | 22.5 |
 III | 127 | 69.8 |
T-stage | ||
 T1 | 24 | 13.2 |
 T2 | 53 | 29.1 |
 T3 | 72 | 39.6 |
 T4 | 33 | 18.1 |
N-stage | ||
 N0 | 34 | 18.7 |
 N1 | 60 | 33 |
 N2 | 76 | 41.8 |
 N3 | 12 | 6.5 |
M-stage | ||
 M0 | 178 | 97.8 |
 M1 | 4 | 2.2 |
Disease stage | ||
 I | 9 | 4.9 |
 II | 35 | 19.2 |
 III | 96 | 52.7 |
 IV | 42 | 23.2 |
DFS (months) | ||
 Median (range) | 23.2 (4.6–156.3) |  |
Treatment | ||
 Induction chemotherapy | 40 | 22 |
 Radiotherapy | 11 | 6 |
 Radiochemotherapy | 130 | 71.4 |
 Chemotherapy | 1 | 0.6 |